Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PIFB vs PIFB+RSB in Cardiac Surgery
NCT04908449Phase 1Completed
- Sponsor
- Medical College of Wisconsin
- Start
- Jun 2023
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in postoperative pain comparing PIFB + RSB (Bupivacaine) with PIFB + RSB (Placebo) (2 arms). Primary endpoints: Pain scores on a 0-10 visual analog scale (VAS) at rest at 24 hours, Pain scores on a 0-10 visual analog scale (VAS) with deep breathing at 24 hours and 1 more. Started Jun 2023; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04908449.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04908449.